Ani Pharmaceuticals Inc (ANIP)
Depreciation & Amortization
$19.64M
Quarterly · Period ending: · USD
ANIP Depreciation & Amortization
Latest reported$19.64Mperiod ending
Latest reported$19.64Mperiod ending
ANIP Quarterly Depreciation & Amortization ($23.85K → $19.64M)
Quarterly Depreciation & Amortization
High-resolution chart · PNG
ANIP depreciation & amortization history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 19,640,000 | |
| 20,919,000 | |
| 22,613,000 | |
| 22,632,000 | |
| 23,281,000 | |
| 22,891,000 | |
| 22,600,000 | |
| 15,748,000 | |
| 14,697,000 | |
| 14,686,000 | |
| 15,194,000 | |
| 15,207,000 | |
| 14,690,000 | |
| 14,700,000 | |
| 15,572,000 | |
| 15,350,000 | |
| 14,174,000 | |
| 14,557,000 | |
| 13,684,000 | |
| 11,346,000 | |
| 11,324,000 | |
| 10,898,000 | |
| 10,899,000 | |
| 11,358,000 | |
| 11,198,000 | |
| 11,183,000 | |
| 9,564,000 | |
| 9,473,000 | |
| 9,472,000 | |
| 16,103,000 | |
| 8,686,000 | |
| 8,548,000 | |
| 8,313,000 | |
| 8,195,000 | |
| 7,022,000 | |
| 7,099,000 | |
| 7,101,000 | |
| 6,706,000 | |
| 5,812,000 | |
| 5,966,000 | |
| 5,956,000 | |
| 4,609,000 | |
| 2,111,000 | |
| 2,047,000 | |
| 1,415,000 | |
| 1,327,000 | |
| 1,282,000 | |
| 1,187,000 | |
| 706,000 | |
| 703,000 | |
| 437,172 | |
| 381,699 | |
| 124,743 | |
| 166,386 | |
| 171,398 | |
| 25,749 | |
| 30,933 | |
| 30,866 | |
| 30,108 | |
| 35,669 | |
| 40,519 | |
| 41,944 | |
| 39,019 | |
| 41,000 | |
| 42,546 | |
| 45,421 | |
| 41,393 | |
| 33,308 | |
| 33,333 | |
| 29,246 | |
| 9,296 | |
| 11,759 | |
| 12,309 | |
| 9,773 | |
| 10,315 | |
| 17,993 | |
| 28,600 | |
| 32,916 | |
| 32,490 | |
| 30,725 | |
| 27,109 | |
| 27,457 | |
| 24,489 | |
| 25,464 | |
| 26,042 | |
| 24,943 | |
| 26,722 | |
| 26,198 | |
| 25,740 | |
| 23,283 | |
| 22,805 | |
| 23,026 | |
| 23,548 | |
| 23,548 | |
| 23,543 | |
| 23,197 | |
| 22,697 | |
| 22,662 | |
| 22,592 | |
| 21,458 |